The Europe Omega 3 Market would witness market growth of 6.6% CAGR during the forecast period (2021-2027).
Omega-3 fatty acids may help with bone and joint health. In a pilot trial of calcium-deficient women, it was discovered that EPA combined with calcium supplements strengthened bones more effectively than calcium supplements alone. This finding implies that omega-3 fatty acids are good for bone health. Furthermore, studies have demonstrated the benefit of omega-3 ingestion in alleviating arthritis symptoms.
Additionally, DHA is a major component of the retina, which is the eye's innermost layer of tissue. DHA has been shown to protect adult eyes against macular degeneration, in studies. Macular degeneration is a type of visual loss that causes hazy vision over time. Omega-3 consumption and eye health have a positive connection, implying that omega-3s may protect against the pathophysiology of eye illnesses.
The growing demand for omega 3 supplements in Europe can be ascribed to an ageing population and an increase in cases of various health disorders, notably in economies such as Germany, France, the Netherlands, and the United Kingdom. With the rise in the cases of various CVDs and mental illness across various nations of the region, the demand for various supplements including omega-3 would witness a rise in the coming years.
The Germany market dominated the Europe Omega 3 Market by Country 2020, and would continue to be a dominant market till 2027; thereby, achieving a market value of $201.3 million by 2027. The UK market would witness a CAGR of 5.8% during (2021 - 2027). Additionally, The France market is anticipated to grow a CAGR of 7.4% during (2021 - 2027).
Based on Type, the market is segmented into Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA), and Alpha-linolenic acid (ALA). Based on Application, the market is segmented into Supplements & Functional Foods, Pharmaceuticals, Infant Formula, Animal Feed & Pet Food and Others. Based on Source, the market is segmented into Marine Source and Plant Source. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
Free Valuable Insights: The Global Omega 3 Market Size will Hit $3 Billion by 2027, at a CAGR of 7%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Aker BioMarine AS, GC Rieber VivoMega AS (GC Rieber group), Epax Norway AS (Pelagia Holding AS), FMC Corporation, BASF SE, Koninklijke DSM N.V., Lonza Group AG, Orkla ASA (Orkla Health), Croda International PLC, and Omega Protein Corporation (Cooke, Inc.).
Scope of the Study
Market Segments Covered in the Report:
By Type
- Docosahexaenoic acid (DHA)
- Eicosapentaenoic acid (EPA), and
- Alpha-linolenic acid (ALA)
By Application
- Supplements & Functional Foods
- Pharmaceuticals
- Infant Formula
- Animal Feed & Pet Food and
- Others
By Source
- Marine Source and
- Plant Source
By Country
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Key Market Players
List of Companies Profiled in the Report:
- Aker BioMarine AS
- GC Rieber VivoMega AS (GC Rieber group)
- Epax Norway AS (Pelagia Holding AS)
- FMC Corporation
- BASF SE
- Koninklijke DSM N.V.
- Lonza Group AG
- Orkla ASA (Orkla Health)
- Croda International PLC
- Omega Protein Corporation (Cooke, Inc.)
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Omega 3 Market, by Type
1.4.2 Europe Omega 3 Market, by Application
1.4.3 Europe Omega 3 Market, by Source
1.4.4 Europe Omega 3 Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Acquisition and Mergers
3.2.3 Product Launches and Product Expansions
3.2.4 Geographical Expansions
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2017-2021)
3.3.2 Key Strategic Move: (Partnerships, Collaborations and Agreements: 2019, Nov – 2021, Feb) Leading Players
Chapter 4. Europe Omega 3 Market by Type
4.1 Europe Docosahexaenoic acid (DHA) Market by Country
4.2 Europe Eicosapentaenoic acid (EPA) Market by Country
4.3 Europe Alpha-linolenic acid (ALA) Market by Country
Chapter 5. Europe Omega 3 Market by Application
5.1 Europe Supplements & Functional Foods Market by Country
5.2 Europe Pharmaceuticals Market by Country
5.3 Europe Infant Formula Market by Country
5.4 Europe Animal Feed & Pet Food Market by Country
5.5 Europe Others Market by Country
Chapter 6. Europe Omega 3 Market by Source
6.1 Europe Marine Source Market by Country
6.2 Europe Plant Source Market by Country
Chapter 7. Europe Omega 3 Market by Country
7.1 Germany Omega 3 Market
7.1.1 Germany Omega 3 Market by Type
7.1.2 Germany Omega 3 Market by Application
7.1.3 Germany Omega 3 Market by Source
7.2 UK Omega 3 Market
7.2.1 UK Omega 3 Market by Type
7.2.2 UK Omega 3 Market by Application
7.2.3 UK Omega 3 Market by Source
7.3 France Omega 3 Market
7.3.1 France Omega 3 Market by Type
7.3.2 France Omega 3 Market by Application
7.3.3 France Omega 3 Market by Source
7.4 Russia Omega 3 Market
7.4.1 Russia Omega 3 Market by Type
7.4.2 Russia Omega 3 Market by Application
7.4.3 Russia Omega 3 Market by Source
7.5 Spain Omega 3 Market
7.5.1 Spain Omega 3 Market by Type
7.5.2 Spain Omega 3 Market by Application
7.5.3 Spain Omega 3 Market by Source
7.6 Italy Omega 3 Market
7.6.1 Italy Omega 3 Market by Type
7.6.2 Italy Omega 3 Market by Application
7.6.3 Italy Omega 3 Market by Source
7.7 Rest of Europe Omega 3 Market
7.7.1 Rest of Europe Omega 3 Market by Type
7.7.2 Rest of Europe Omega 3 Market by Application
7.7.3 Rest of Europe Omega 3 Market by Source
Chapter 8. Company Profiles
8.1 Aker BioMarine AS
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expenses
8.1.5 Recent strategies and developments:
8.1.5.1 Partnerships, Collaborations, and Agreements:
8.1.5.2 Acquisition and Mergers:
8.2 GC Rieber VivoMega AS (GC Rieber group)
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Recent strategies and developments:
8.2.3.1 Partnerships, Collaborations, and Agreements:
8.2.3.2 Product Launches and Product Expansions:
8.2.3.3 Geographical Expansions:
8.3 Epax Norway AS (Pelagia Holding AS)
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.4 FMC Corporation
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Regional Analysis
8.4.4 Research & Development Expenses
8.5 BASF SE
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expense
8.5.5 Recent strategies and developments:
8.5.5.1 Product Launches and Product Expansions:
8.6 Koninklijke DSM N.V.
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expense
8.6.1 Recent strategies and developments:
8.6.1.1 Acquisition and Mergers:
8.7 Lonza Group AG
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expenses
8.7.5 Recent strategies and developments:
8.7.5.1 Partnerships, Collaborations, and Agreements:
8.8 Orkla ASA (Orkla Health)
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental and Regional Analysis
8.8.4 Research & Development Expenses
8.8.5 Recent strategies and developments:
8.8.5.1 Partnerships, Collaborations, and Agreements:
8.8.5.2 Acquisition and Mergers:
8.9 Croda International PLC
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Segmental and Regional Analysis
8.9.4 Research & Development Expenses
8.9.5 Recent strategies and developments:
8.9.5.1 Acquisition and Mergers:
8.10. Omega Protein Corporation (Cooke, Inc.)
8.10.1 Company Overview
TABLE 1 Europe Omega 3 Market, 2017 - 2020, USD Million
TABLE 2 Europe Omega 3 Market, 2021 - 2027, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– Omega 3 Market
TABLE 4 1.2.2 Acquisition and Mergers– Omega 3 Market
TABLE 5 Product Launches And Product Expansions – Omega 3 Market
TABLE 6 geographical Expansions – Omega 3 Market
TABLE 7 Europe Omega 3 Market by Type, 2017 - 2020, USD Million
TABLE 8 Europe Omega 3 Market by Type, 2021 - 2027, USD Million
TABLE 9 Europe Docosahexaenoic acid (DHA) Market by Country, 2017 - 2020, USD Million
TABLE 10 Europe Docosahexaenoic acid (DHA) Market by Country, 2021 - 2027, USD Million
TABLE 11 Europe Eicosapentaenoic acid (EPA) Market by Country, 2017 - 2020, USD Million
TABLE 12 Europe Eicosapentaenoic acid (EPA) Market by Country, 2021 - 2027, USD Million
TABLE 13 Europe Alpha-linolenic acid (ALA) Market by Country, 2017 - 2020, USD Million
TABLE 14 Europe Alpha-linolenic acid (ALA) Market by Country, 2021 - 2027, USD Million
TABLE 15 Europe Omega 3 Market by Application, 2017 - 2020, USD Million
TABLE 16 Europe Omega 3 Market by Application, 2021 - 2027, USD Million
TABLE 17 Europe Supplements & Functional Foods Market by Country, 2017 - 2020, USD Million
TABLE 18 Europe Supplements & Functional Foods Market by Country, 2021 - 2027, USD Million
TABLE 19 Europe Pharmaceuticals Market by Country, 2017 - 2020, USD Million
TABLE 20 Europe Pharmaceuticals Market by Country, 2021 - 2027, USD Million
TABLE 21 Europe Infant Formula Market by Country, 2017 - 2020, USD Million
TABLE 22 Europe Infant Formula Market by Country, 2021 - 2027, USD Million
TABLE 23 Europe Animal Feed & Pet Food Market by Country, 2017 - 2020, USD Million
TABLE 24 Europe Animal Feed & Pet Food Market by Country, 2021 - 2027, USD Million
TABLE 25 Europe Others Market by Country, 2017 - 2020, USD Million
TABLE 26 Europe Others Market by Country, 2021 - 2027, USD Million
TABLE 27 Europe Omega 3 Market by Source, 2017 - 2020, USD Million
TABLE 28 Europe Omega 3 Market by Source, 2021 - 2027, USD Million
TABLE 29 Europe Marine Source Market by Country, 2017 - 2020, USD Million
TABLE 30 Europe Marine Source Market by Country, 2021 - 2027, USD Million
TABLE 31 Europe Plant Source Market by Country, 2017 - 2020, USD Million
TABLE 32 Europe Plant Source Market by Country, 2021 - 2027, USD Million
TABLE 33 Europe Omega 3 Market by Country, 2017 - 2020, USD Million
TABLE 34 Europe Omega 3 Market by Country, 2021 - 2027, USD Million
TABLE 35 Germany Omega 3 Market, 2017 - 2020, USD Million
TABLE 36 Germany Omega 3 Market, 2021 - 2027, USD Million
TABLE 37 Germany Omega 3 Market by Type, 2017 - 2020, USD Million
TABLE 38 Germany Omega 3 Market by Type, 2021 - 2027, USD Million
TABLE 39 Germany Omega 3 Market by Application, 2017 - 2020, USD Million
TABLE 40 Germany Omega 3 Market by Application, 2021 - 2027, USD Million
TABLE 41 Germany Omega 3 Market by Source, 2017 - 2020, USD Million
TABLE 42 Germany Omega 3 Market by Source, 2021 - 2027, USD Million
TABLE 43 UK Omega 3 Market, 2017 - 2020, USD Million
TABLE 44 UK Omega 3 Market, 2021 - 2027, USD Million
TABLE 45 UK Omega 3 Market by Type, 2017 - 2020, USD Million
TABLE 46 UK Omega 3 Market by Type, 2021 - 2027, USD Million
TABLE 47 UK Omega 3 Market by Application, 2017 - 2020, USD Million
TABLE 48 UK Omega 3 Market by Application, 2021 - 2027, USD Million
TABLE 49 UK Omega 3 Market by Source, 2017 - 2020, USD Million
TABLE 50 UK Omega 3 Market by Source, 2021 - 2027, USD Million
TABLE 51 France Omega 3 Market, 2017 - 2020, USD Million
TABLE 52 France Omega 3 Market, 2021 - 2027, USD Million
TABLE 53 France Omega 3 Market by Type, 2017 - 2020, USD Million
TABLE 54 France Omega 3 Market by Type, 2021 - 2027, USD Million
TABLE 55 France Omega 3 Market by Application, 2017 - 2020, USD Million
TABLE 56 France Omega 3 Market by Application, 2021 - 2027, USD Million
TABLE 57 France Omega 3 Market by Source, 2017 - 2020, USD Million
TABLE 58 France Omega 3 Market by Source, 2021 - 2027, USD Million
TABLE 59 Russia Omega 3 Market, 2017 - 2020, USD Million
TABLE 60 Russia Omega 3 Market, 2021 - 2027, USD Million
TABLE 61 Russia Omega 3 Market by Type, 2017 - 2020, USD Million
TABLE 62 Russia Omega 3 Market by Type, 2021 - 2027, USD Million
TABLE 63 Russia Omega 3 Market by Application, 2017 - 2020, USD Million
TABLE 64 Russia Omega 3 Market by Application, 2021 - 2027, USD Million
TABLE 65 Russia Omega 3 Market by Source, 2017 - 2020, USD Million
TABLE 66 Russia Omega 3 Market by Source, 2021 - 2027, USD Million
TABLE 67 Spain Omega 3 Market, 2017 - 2020, USD Million
TABLE 68 Spain Omega 3 Market, 2021 - 2027, USD Million
TABLE 69 Spain Omega 3 Market by Type, 2017 - 2020, USD Million
TABLE 70 Spain Omega 3 Market by Type, 2021 - 2027, USD Million
TABLE 71 Spain Omega 3 Market by Application, 2017 - 2020, USD Million
TABLE 72 Spain Omega 3 Market by Application, 2021 - 2027, USD Million
TABLE 73 Spain Omega 3 Market by Source, 2017 - 2020, USD Million
TABLE 74 Spain Omega 3 Market by Source, 2021 - 2027, USD Million
TABLE 75 Italy Omega 3 Market, 2017 - 2020, USD Million
TABLE 76 Italy Omega 3 Market, 2021 - 2027, USD Million
TABLE 77 Italy Omega 3 Market by Type, 2017 - 2020, USD Million
TABLE 78 Italy Omega 3 Market by Type, 2021 - 2027, USD Million
TABLE 79 Italy Omega 3 Market by Application, 2017 - 2020, USD Million
TABLE 80 Italy Omega 3 Market by Application, 2021 - 2027, USD Million
TABLE 81 Italy Omega 3 Market by Source, 2017 - 2020, USD Million
TABLE 82 Italy Omega 3 Market by Source, 2021 - 2027, USD Million
TABLE 83 Rest of Europe Omega 3 Market, 2017 - 2020, USD Million
TABLE 84 Rest of Europe Omega 3 Market, 2021 - 2027, USD Million
TABLE 85 Rest of Europe Omega 3 Market by Type, 2017 - 2020, USD Million
TABLE 86 Rest of Europe Omega 3 Market by Type, 2021 - 2027, USD Million
TABLE 87 Rest of Europe Omega 3 Market by Application, 2017 - 2020, USD Million
TABLE 88 Rest of Europe Omega 3 Market by Application, 2021 - 2027, USD Million
TABLE 89 Rest of Europe Omega 3 Market by Source, 2017 - 2020, USD Million
TABLE 90 Rest of Europe Omega 3 Market by Source, 2021 - 2027, USD Million
TABLE 91 Key Information – Aker BioMarine AS
TABLE 92 Key Information – GC Rieber VivoMega AS
TABLE 93 Key Information – Epax Norway AS
TABLE 94 Key Information – FMC Corporation
TABLE 95 Key Information – BASF SE
TABLE 96 Key Information – Koninklijke DSM N.V.
TABLE 97 Key Information – Lonza Group AG
TABLE 98 Key Information – Orkla ASA
TABLE 99 Key Information – Croda International PLC
TABLE 100 key information – Omega Protein Corporation
List of Figures
FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2017-2021)
FIG 4 Key Strategic Move: (Partnerships, Collaborations and Agreements: 2019, Nov – 2021, Feb) Leading Players
FIG 5 Recent strategies and developments: Aker BioMarine AS
FIG 6 Recent strategies and developments: GC Rieber VivoMega AS
FIG 7 Recent strategies and developments: Orkla ASA